SCHEMBL18700396

SCHEMBL18700396

C=C(CC(=O)N(CC)CC)C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.44
HSD17B10 Q99714 3/20 0.40
ALOX15 P16050 2/20 0.40
ALDH1A1 P00352 3/20 0.38
ALDH2 P05091 2/20 0.38
TET2 Q6N021 4/20 0.34
KDM4E B2RXH2 1/20 0.34
MDM2 Q00987 1/20 0.34
MMP1 P03956 1/20 0.33
MMP2 P08253 1/20 0.33
MMP3 P08254 1/20 0.33
MMP8 P22894 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
TET3 O43151 1/20 0.32
TET1 Q8NFU7 1/20 0.32
TSHR P16473 2/20 0.32
GRIK1 P39086 1/20 0.31
GRIK2 Q13002 1/20 0.31
GRM1 Q13255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2097527 0.77 LMNA (0.60) LMNAHSD17B10ALDH1A1ALDH2MMP1
SCHEMBL15512105 0.76 LMNA (0.48) LMNAHSD17B10ALDH1A1ALDH2KDM4E
SCHEMBL18279538 0.76 LMNA (0.48) LMNAHSD17B10ALDH1A1ALDH2KDM4E
SCHEMBL18279540 0.76 LMNA (0.48) LMNAHSD17B10ALDH1A1ALDH2KDM4E
SCHEMBL5282077 0.76 ALOX15 (0.43) HSD17B10ALOX15ALDH1A1TET2TET3
SCHEMBL11189562 0.75 LMNA (0.52) LMNAHSD17B10ALDH1A1ALDH2MMP1
SCHEMBL17284813 0.75 TET2 (0.36) HSD17B10ALOX15TET2TET3TET1
SCHEMBL15570361 0.74 FNTA (0.42) LMNAHSD17B10ALDH1A1ALDH2KDM4E
SCHEMBL11057516 0.74 ALDH1A1 (0.52) LMNAHSD17B10ALOX15ALDH1A1TET2
SCHEMBL15570359 0.74 FNTA (0.42) LMNAHSD17B10ALDH1A1ALDH2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180066113-A9 AMINOSILOXANE POLYMER AND METHOD OF FORMING DOW SILICONES CORPORATION 2018-03-08 US disclosed
US-20170096533-A1 AMINOSILOXANE POLYMER AND METHOD OF FORMING DOW CORNING (US) 2017-04-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180066113-A9 AMINOSILOXANE POLYMER AND METHOD OF FORMING HRH3, H1-2, H1-0 LMNA 1867/4885HSD17B10 476/4885ALOX15 499/4885
US-20170096533-A1 AMINOSILOXANE POLYMER AND METHOD OF FORMING HRH3, H1-2, H1-0 LMNA 1867/4885HSD17B10 476/4885ALOX15 499/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.